Natural and embedded regulatory compliance

Complying with the FDA regulations requires more than one person in an office updating policies.

Every person and every supplier needs to follow processes that are fit for purpose. Quality improvement must be part of the culture. Compliance is a holistic, integrated approach. And innovation must be carefully managed in order to protect patient and consumer safety.

Qualsys provides quality management software which has helped 100’s of our customers to achieve FDA go-to-market approval.

EQMS by Qualsys bakes best practice into your employee’s daily routine and you have confidence all the compliance tools are working in the background. Compliance is natural, embedded and almost invisible for the end user.

Issues management application

Much more than document control

EQMS doesn’t just enable you to have unshakeable control over any document, file or policy.

It’s an integrated management system tool which joins up your processes, embeds risk based thinking, enables the management of staff competency, and provides a framework for internal and supplier auditing.

For example, a business using EQMS may see a quality event in a laboratory. This is raised by an employee using Kiosk. Based on the information and data collected, this creates new record and job type in Issue Manager. This starts a workflow which sends notifications to the quality or health and safety team. This team can then investigate the root cause and send actions to employees in the system, update any documentation and send process changes to relevant employees for ‘read and understood’, schedule a new training record, update a risk register, and add the issue to any upcoming audits to check the corrective action was fit for purpose.

This holistic and integrated approach to quality and regulatory compliance builds a stronger, unified business. Your processes, policies and procedures become stronger because everything is connected. And when there’s an auditor, our customers say how they enjoy inspections because they know everything is there, compliant and recorded properly.

Complex circle

FDA-compliant features

Compliance is embedded and natural. All the controls work in the background.

Complete access controls

The authenticity, integrity and confidentiality of electronic records is always protected in EQMS.

Incorruptible audit trails

Secure, time-stamped audit trails capture who, what, when, where, why and how a change has occurred.

FDA compliant electronic signatures and records

Demonstrate employees have read and understood changes, documents and policies.

Data integrity best practices

EQMS is built around ALCOA+ data integrity principles.

Complete validation package

From URS support to implementation to updating the software, we support your validation.

Demonstrate staff competency

Store certifications, training records, and examinations to demonstrate staff operating under the organisation are competent.

100's of life science, medical device and pharmaceutical businesses use our software to comply with FDA regulations

Sodexo ISO 55000 software
Medical device manufacturers ISO 13485 DYSIS
Indivior medical device compliance
Cardiome quality and training record management software
Biocair logistics medical supply business
Elementis chemicals quality management software system
Monosol quality management system ISO 9001
Synexus clinical trial management software
Vision RT medical device quality management
pharmaceutical quality management software
Pharma compliance management software
pharmaceutical quality control and assurance software and systems
pharmaceutical qms software

Read our life science case studies

Don’t just take our word for it. Read our case study booklet to see the results we’ve achieved for businesses across the globe.

Validation brochure

Learn about our five-phased approach to managing computer systems validation, and how we help you to comply with regulations and Standards such as ISO 13485:2016, GAMP 5, ICH GCP E6, FDA 21 CFR Part 11, Eudralex Volume 4 Annex 11, and the EU Electronic signatures directive.

See how our software helps you to comply with FDA

You may also be interested in...

Medical device quality management software
Protecting your patients and getting your medical devices to market starts with a strong quality and compliance management system. Our software and services guide you through the entire process, ensuring you have a best-practice system which meets the most rigorous compliance requirements.
Read more
Life science
You need to prove your products are safe to use and will deliver the intended results. Our software provides you with a best-practice framework and all the evidence you need to keep control of your processes and demonstrate consistency.
Read more
Global pharmaceutical businesses, NHS trusts and other life science businesses have validated iterations of EQMS as compliant with the requirements of regulations such as GAMP 5, ISO 9001, ICH GCP E6 and FDA 21CFR Part 11, and electronic signature legislation such as the EU Electronic Signatures Dir...
Read more
ISO 14971
ISO 14971 defines international requirements for risk management systems for medical devices. Our software helps you to implement best practices throughout the entire lifecycle of your medical device.
Read more
ISO 13485
Hundreds of companies use Qualsys's software to plan and manage a medical device quality management system which meets ISO 13485 best practices. Find out why we're the UK's highest rated solution provider.
Read more

More articles about FDA

FDA 21 CFR Part 11: How EQMS helps PPT
Qualsys is one of the UK's leading providers of governance, risk and compliance management software. Since 1995, Qualsys has been on a mission to transform the role of quality from one of administration to a strategic tool.
Read more
5 FDA & MHRA changes to know about in 2019
Every drug, device and clinical company wants to be able to predict how regulations and laws are going to impact their current and future processes. Last month, during our GxP Product Advisory Group event, we invited Sion Wyn, who assisted the FDA as a consultant with its re-examination of 21 CFR P...
Read more